With the arrival of June comes the first true glimmers of a patently American summer: vibrant Pride parades, weekend barbecues, festivals galore — and the looming release of the Supreme Court's most contentious rulings. Among this year's slate is a landmark case on gender-affirming care for minors that will have sprawling implications for transgender youth and adults, alongside the potential to upend decades of anti-discrimination law.
U.S. v. Skrmetti concerns Tennessee's 2023 gender-affirming care ban, which prohibits physicians from providing medical treatments like hormone therapy or puberty blockers to minors seeking to transition. During oral argument in December 2024, the Biden administration argued that a patient's birth-assigned sex determines what treatment the law prohibits or allows; for example, providing someone assigned female at birth with estrogen therapy is not prohibited under the law, while providing that treatment to a child assigned male at birth is.
